Select Page

Ind-Swift (Small Cap - Next Multibagger) Share Target 2024, 2025 To 2039

Ind-Swift Limited

Company Logo Price: ₹26.03
52 Week Low: ₹14.30
52 Week High: ₹32.55
Market Capital: 109.57 Crore (Smallcap)
Healthcare -> Drug Manufacturers—Specialty & Generic
Show Table of Contents

To predict the Ind-Swift's future market prices, we harnessed 2 dynamic approaches:

Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices

Approach 1: Technical Analysis Paired With Price Action

Ind-Swift Share Price Target For 2024

The line chart displays the monthly closing prices of Ind-Swift with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.

For detailed target and stop loss values for Ind-Swift shares in 2024, see the table below.

Ind-Swift Share Price Target Table For 2024

Level Value Analysis
2024 Target 3 28.4 (+9.1%) Price Action: 08 Apr 2024 High
2024 Target 2 28.1 (+7.95%) Price Action: May 2012 High
2024 Target 1 27.8 (+6.79%) Price Action: Oct 2006 Low
Current Price 26.03 Ind-Swift's share price as of 26 Dec 2024
Stop Loss 1 25.2 (-3.19%) Price Action: Nov 2009 Low
Stop Loss 2 24.93 (-4.23%) Price Action: Nov 2024 High
Stop Loss 3 24.65 (-5.31%) Price Action: 26 Apr 2024 High

Short-Term Technical Outlook

Current Technical Position: Ind-Swift is showing bullish momentum with price above both 25-day and 50-day moving averages.

Key Technical Level: The 25-day moving average at ₹25.05 serves as the nearest technical reference point.

Historical Returns: 3-month: +8.41% | 6-month: +20.51% | 1-year: +43.02%

Ind-Swift Share Price Target For 2025

The line chart displays the monthly closing prices of Ind-Swift with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.

For detailed target and stop loss values for Ind-Swift shares in 2025, see the table below.

Ind-Swift Share Price Target Table For 2025

Level Value Analysis
2025 Target 3 38.98 (+49.75%) Price Action: Chart
2025 Target 2 38.25 (+46.94%) Price Action: Chart
2025 Target 1 37.87 (+45.48%) Fibonacci Extension Level 64.90%
Current Price 26.03 Ind-Swift's share price as of 26 Dec 2024
Stop Loss 1 23.31 (-10.45%) Price Action: 06 Aug 2024 Low
Stop Loss 2 23.06 (-11.41%) Price Action: 05 Sep 2024 Low
Stop Loss 3 22.81 (-12.38%) Price Action: 18 Jul 2024 High

Long-Term Technical Outlook

52-Week Range Analysis: Ind-Swift is currently trading at 64.3% of its 52-week range (₹14.3 - ₹32.55).

Long-Term Trend Analysis: The stock is maintaining a bullish long-term trend, trading above both 150-day and 250-day moving averages.

Long-Term Performance: 1-year: +43.02% | 3-year: +104.96% | 5-year: +753.44%

Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!

Join our WhatsApp group

Join our Telegram group

Your phone number will be HIDDEN to other users.

Approach 2: Machine Learning By Studying Historical Prices

Ind-Swift Share Price Target Chart and Table From 2024, 2025, 2026 to 2039

Year Target 1 Target 1 YoY Chg % Target 2
Current Price ₹26.03
2024 ₹21.62 -16.94% ₹22.20
2025 ₹22.90 +5.92% ₹23.43
2026 ₹22.58 -1.39% ₹22.92
2027 ₹21.83 -3.32% ₹23.10
2028 ₹22.17 +1.55% ₹22.77
2029 ₹20.42 -7.89% ₹22.44
2030 ₹21.62 +5.87% ₹22.11
2031 ₹21.30 -1.48% ₹21.62
2032 ₹20.57 -3.42% ₹21.78
2033 ₹20.87 +1.45% ₹21.45
2034 ₹19.21 -7.95% ₹21.12
2035 ₹20.33 +5.83% ₹20.79
2036 ₹20.01 -1.57% ₹20.31
2037 ₹19.31 -3.49% ₹20.46
2038 ₹19.58 +1.39% ₹20.13
2039 ₹18.50 -5.51% ₹19.81

Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.

Ind-Swift Brief Company Overview

Ind-Swift Limited: A Comprehensive Overview Ind-Swift Limited is a renowned pharmaceutical company in India, established in 1983. The company offers a diverse product range, including formulations, finished goods, active pharmaceutical ingredients, and herbal products. With a... focus on therapeutic segments, their medicines cater to various needs such as ENT, dentistry, anti-infectives, and cardiology. Ind-Swift has a strong market presence, exporting to over 50 countries and licensing its products internationally. Its commitment to innovation and quality has earned it a respected reputation in the industry.

Ind-Swift Financial Performance

Metric Value Description
Market Capital 109.57 Crore Market valuation of Ind-Swift's shares.
Revenue (TTM) 467.56 Crore Total revenue generated by Ind-Swift over the past twelve months.
Net Income (TTM) +40.1 Crore Net Profit or Loss after all the expenses over the past twelve months.
Operating Margin -1.89% Income from operations as a percentage of revenue, before taxes and interest.
Profit Margin +8.57% Net income as a percentage of revenue, after all expenses.
Revenue Growth
(Quarterly)
-23.4% Change in revenue compared to the previous quarter.
Earnings Growth
(YOY Quarterly)
+1,095.4% Change in earnings compared to the same quarter last year.
Debt-to-Equity
(D/E) Ratio
-1.47 Company's total debt divided by total shareholder equity.
Total Debt 1,013.99 Crore Sum of Ind-Swift's current & long-term financial obligations.
Total Cash 63.13 Crore Total amount of liquid funds available to Ind-Swift.
Beta -0.11 Beta is less than 1 indicating that the Ind-Swift's price is less volatile than the market.

Is Ind-Swift A Good Buy For Long Term?

Ind-Swift, a small-cap stock with a market capitalization of ₹109.57 crore, shows mixed signals. While it boasts impressive 3-year (430.12%) and 5-year (189.50%) returns, and a healthy profit margin of 8.57% (₹40.1 crore net profit on ₹467.56 crore revenue in TTM), its substantial debt (₹1013.99 crore) against a meager cash balance (₹63.13 crore) raises concerns. Recent performance is also weak, with a -24.61% return in the past 3 months. Therefore, considering the high debt and fluctuating performance, it's currently not a good buy for the long term. More in-depth analysis is needed.

Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.

All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.